L-arginine and Vitamin D Adjunctive Therapy in Pulmonary Tuberculosis (TB)
Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether adjunctive L-arginine and vitamin D can
improve response to standard short course TB therapy in people with newly diagnosed pulmonary
TB.
Phase:
Phase 3
Details
Lead Sponsor:
Menzies School of Health Research
Collaborators:
Australian National University National Institute of Health Research and Development, Ministry of Health Republic of Indonesia